Generex Biotechnology Immune-response strategy to be tested for use against cancer
17-May-2005 -
Generex Biotechnology Corporation announced that its wholly owned subsidiary, Antigen Express, has signed an agreement with Dr. Ralph Reisfeld, Ph.D., professor of immunology at The Scripps Research Institute, to test the potency of a modified DNA vaccine for treatment of various forms of ...
antigens
bacteria
Expression
+3